MARIANNE PEACOCK

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TRAVERSE CITY, MI NPI 1386631455

General Payments — all program years on this page

$3,789.70

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 243
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $360.64 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $360.6420

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $278.7316
NOVARTIS PHARMACEUTICALS CORPORATION $25.401
UCB, Inc. $23.831
Janssen Biotech, Inc. $18.181
Pharmacosmos Therapeutics Inc. $14.501

By program year

Program yearAmountRecords
2021 $1,040.7773
2022 $926.8664
2023 $1,461.4386
2024 $360.6420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078766677 Janssen Biotech, Inc. $18.18 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087223105 Novartis Pharmaceuticals Corporation $25.40 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350390 Amgen Inc. $11.96 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350392 Amgen Inc. $27.74 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350394 Amgen Inc. $11.66 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350396 Amgen Inc. $13.62 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350398 Amgen Inc. $17.15 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350400 Amgen Inc. $15.27 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350402 Amgen Inc. $27.38 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350404 Amgen Inc. $25.76 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350406 Amgen Inc. $12.11 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350408 Amgen Inc. $13.45 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350410 Amgen Inc. $15.50 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350412 Amgen Inc. $15.96 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350414 Amgen Inc. $16.44 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350416 Amgen Inc. $15.77 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350418 Amgen Inc. $22.75 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117350420 Amgen Inc. $16.21 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143019773 UCB, Inc. $23.83 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154831744 Pharmacosmos Therapeutics Inc. $14.50 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.